Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1270 participants.
Also called NCT04097145
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,270 participants
- Sponsor
- Registry
-
NCT04097145
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04097145. Randomized; no masking; primary purpose treatment. Start 2019-12-11 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- Acronym
- CLASP II TR
- Condition
- Tricuspid Regurgitation
- Condition
- Tricuspid Valve Insufficiency
- Condition
- Tricuspid Valve Disease
- Intervention (Device)
- Edwards PASCAL System
- Intervention (Drug)
- Optimal Medical Therapy
- Intervention (Device)
- Edwards PASCAL System
- Intervention (Device)
- Edwards PASCAL System
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct04097145- Content hash
c6f651d6391211980cfa229d1059316be5ab58b911cec16584e76d9aa4f29f03